Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $200M Series A (Mar 2026) at $2B+ valuation led by AON Consulting. 91%+ medication adherence. GLP-1 benefits platform for employers. Linda Yaccarino CEO.
eMed is a GLP-1 and metabolic health benefits platform built specifically for employer-sponsored health plans, the fastest-growing category in US workplace benefits. The company raised $200 million in Series A financing in March 2026 at a $2 billion+ valuation led by AON Consulting, with backing from Linda Yaccarino (former Twitter/X CEO, now eMed CEO) and Tom Brady. Claiming 91%+ medication adherence rates, eMed positions itself as the most effective GLP-1 benefits program available to employers.
Raised $107M strategic (May 2025) from Aldrich Capital. 200+ hospitals, 12,000+ clinicians. Patented Soliton AI engine. Global expansion in 2026. Spans care management, population health, and RCM.
Persivia is a unified AI healthcare platform spanning care management, population health analytics, and revenue cycle operations — one of the few integrated platforms that addresses both the clinical and financial sides of health system performance simultaneously. The company raised $107 million in strategic financing from Aldrich Capital Partners in May 2025, and is actively expanding globally in 2026 with its CareSpace platform deployed at 200+ hospitals and used by 12,000+ clinicians.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.